3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
3
Breast Neoplasms
2
Thymoma
1
Hypoxia
1
Hereditary Sensory and Autonomic Neuropathies
1
Extensive Stage Small Cell Lung Cancer
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
fluoromisonidazole
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
TH 302
1
Nitroglycerin
1
NVP-BKM120
1
Atovaquone
1
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
1
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
NVP-BKM120
×
Thoracic
×
Clear all
NCT02128724
2019-08-01
BKM120
University of Oxford
Phase 1
Completed
21 enrolled
23 charts